Last updated 7 months ago

Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA

60 patients around the world
Available in Brazil
The comorbidity between OSA and insomnia (COMISA) is common. COMISA leads to additive impairment of quality of sleep and quality of life compared to patients with insomnia or OSA alone. Patients with COMISA demonstrate worse adherence to CPAP compared to patients with isolated OSA. The best therapeutic approach for patients with COMISA is still unclear. Hypnotics have not been tested among patients with COMISA and indication for CPAP. The investigators will compare the effect of Eszopiclone 3mg or placebo for 14 days on adherence to CPAP after 30 days and after 6 months. In addition, the investigators will assess the effect eszopiclone on insomnia severity, quality of life, anxiety.
University of Sao Paulo General Hospital
1Research sites
60Patients around the world

This study is for people with

Sleep disorders
Sleep apnea

Requirements for the patient

To 75 Years
All Gender

Medical requirements

Sites

Instituto do Coração do HCFMUSP
Recruiting
Av. Dr. Enéas Carvalho de Aguiar, 44 - 1° andar, sala 2 - Cerqueira César, São Paulo - SP, CEP: 05403-000
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy